In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P .01 for all). Specific ...
Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...
The fact that the complement system is activated during immune-complex glomerular disease has been known for nearly 50 years. Detection of complement deposition in the glomerulus using immunochemistry ...
Creative Biolabs’ expanded primary neuron portfolio includes cortical, hippocampal, dopaminergic, and sensory neurons isolated and characterized under stringent quality control (QC) standards and ...
Oliver Cuenca explores the potential and limitations of flight-sharing platforms as a means to improving aeromedical ...
Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to ...
Pathogens in the circulation that become coated with fragments of complement component 3 (C3) — a process known as C3 opsonization — are phagocytosed by Kupffer cells — liver-resident macrophages — ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual ...
Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 ...
From 4L80E and Allison six-speeds to the 10R80 and Gear Vendors, these overdrive transmissions reshaped street performance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results